3438 Post marketing surveillance (PMS) in Japan for soft tissue sarcoma (STS) patients treated with pazopanib. (September 2015) - Kawai, A.; Araki, N.; Ando, Y.; Nakano, K.; Machida, M.; Yoshida, P.